80 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
. There are equivalent processes and risks applicable to clinical trial applications in other countries, including countries in the European Union (“EU … and
Reimbursement” and “Business – Other Government Regulation Outside of the United States – Regulation in the European Union” for a more detailed
424B3
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Prospectus supplement
4:06pm
in a Material Adverse Effect. None of the Company’s or any Subsidiary’s employees is a member of a labor union that relates to such employee’s relationship … ”) of the United States Treasury Department, the U.S. Department of State, the United Nations Security Council, the European Union, His Majesty’s Treasury
8-K
EX-10.1
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
or any Subsidiary’s employees is a member of a labor union that relates to such employee’s relationship with the Company, and neither the Company nor … , the U.S. Department of State, the United Nations Security Council, the European Union, His Majesty’s Treasury or any other relevant sanctions authority
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
and risks applicable to clinical trial applications in other countries, including countries in the European Union (“EU”).
We may not have the financial … Government Regulation Outside of the United States – Regulation in the European Union” for a more detailed description of the government regulations
POS AM
bhp3wujj 9i
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
424B3
wppf2basv9erkbg
8 Dec 23
Prospectus supplement
4:06pm
8-K
EX-10.1
v5h1ha
8 Dec 23
Spyre Therapeutics Announces $180 Million Private Placement
8:45am